» » »

Gene Mutation and Endometrial Cancer Cary NC

A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments. The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women#r3 with a highly aggressive form of the disease known as endometrioid endometrial cancer.

Chiropractic Partners
(919) 467-7797
1125 Kildaire Farm Rd
Cary, NC

Data Provided by:
Mudryk Family-Chiropractic, PA
(919) 238-7736
401 Keisler Dr. Suite 100
Cary, NC

Data Provided by:
Mayfair Animal Hospital
(919) 467-6146
1130 SW Maynard Rd
Cary, NC

Data Provided by:
Milham Family Chiropractic
(919) 238-7540
900 W Williams St
Apex, NC

Data Provided by:
Roger B. Russell
(919) 785-0505
3633 Harden Road
Raleigh, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Kildaire Animal Medical Center
(919) 469-8086
1409 Kildaire Farm Rd.
Cary, NC

Data Provided by:
Cat Clinic Of Cary
(919) 469-9000
2464 SW Cary Pkwy
Cary, NC

Data Provided by:
Team Chiropractic & Sports Medicine - Cary
(919) 650-2447
258 Towne Village Drive
Cary, NC

Data Provided by:
Chiropractic First Pllc
(919) 443-1851
1011 West Williams St. Ste 104
Apex, NC

Data Provided by:
Glenn M Davis
(919) 785-1220
2304 Wesvill Court
Raleigh, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Data Provided by:

Gene Mutation and Endometrial Cancer

Provided By:

WEDNESDAY, May 27 (HealthDay News) -- A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments.

The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women with a highly aggressive form of the disease known as endometrioid endometrial cancer.

The ATR gene directs cellular responses to DNA damage, the researchers noted.

"Women whose endometrial cancers have an ATR mutation have more than four times the risk of having their cancer return," study author Dr. Israel Zighelboim, a gynecologic oncologist, said in a news release from the university. "This and similar tumor biomarkers could potentially identify those patients most in danger of recurrence and guide the development of treatments aimed at these more aggressive tumors."

ATR mutations were found in about 5 percent of the 248 endometrioid endometrial tumor samples analyzed by the researchers. Women with ATR mutations were 4.29 times more likely to have the cancer recur after treatment and 3.88 times more likely to die.

The study appears online in the Journal of Clinical Oncology.

Zighelboim and his research colleagues plan to see if the prognostic value of ATR mutations can be confirmed in a larger group of women and to investigate the association between ATR mutations and treatment response after cancer recurrence.

More information

The American Cancer Society has more about endometrial cancer.

SOURCE: Washington University School of Medicine in St. Louis, news release, May 26, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com